NASDAQ:SRTS - Sensus Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $5.30 -0.23 (-4.16 %) (As of 05/20/2019 04:00 PM ET)Previous Close$5.5250Today's Range$5.2950 - $5.4452-Week Range$5.22 - $9.23Volume21,883 shsAverage Volume48,936 shsMarket Capitalization$87.55 millionP/E RatioN/ADividend YieldN/ABeta-0.53 ProfileAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida. Receive SRTS News and Ratings via Email Sign-up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SRTS Previous Symbol CUSIPN/A CIK1494891 Webwww.sensushealthcare.com Phone561-922-5808Debt Debt-to-Equity RatioN/A Current Ratio6.09 Quick Ratio5.03Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$26.43 million Price / Sales3.31 Cash FlowN/A Price / Cash FlowN/A Book Value$1.65 per share Price / Book3.21Profitability EPS (Most Recent Fiscal Year)($0.14) Net Income$-2,020,000.00 Net Margins-11.65% Return on Equity-13.34% Return on Assets-10.09%Miscellaneous Employees48 Outstanding Shares16,518,000Market Cap$87.55 million Next Earnings Date8/1/2019 (Estimated) OptionableNot Optionable Sensus Healthcare (NASDAQ:SRTS) Frequently Asked Questions What is Sensus Healthcare's stock symbol? Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS." How were Sensus Healthcare's earnings last quarter? Sensus Healthcare Inc (NASDAQ:SRTS) released its earnings results on Thursday, May, 9th. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.02) by $0.11. The business earned $5.44 million during the quarter, compared to analysts' expectations of $7.81 million. Sensus Healthcare had a negative return on equity of 13.34% and a negative net margin of 11.65%. View Sensus Healthcare's Earnings History. When is Sensus Healthcare's next earnings date? Sensus Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, August 1st 2019. View Earnings Estimates for Sensus Healthcare. What price target have analysts set for SRTS? 7 brokers have issued twelve-month price objectives for Sensus Healthcare's shares. Their forecasts range from $5.00 to $12.50. On average, they expect Sensus Healthcare's stock price to reach $10.00 in the next twelve months. This suggests a possible upside of 88.7% from the stock's current price. View Analyst Price Targets for Sensus Healthcare. What is the consensus analysts' recommendation for Sensus Healthcare? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sensus Healthcare. What are Wall Street analysts saying about Sensus Healthcare stock? Here are some recent quotes from research analysts about Sensus Healthcare stock: 1. HC Wainwright analysts commented, "Our price target is derived from an EV-to-sales multiple of 6.0x and TTM revenue ($1.57/share). Risks include, but are not limited to: (1) failure of SRT and IORT systems to achieve commercial success due to reimbursement, penetration rate, and/or competition; (2) failure of other potential pipeline products; and (3) potential dilution risk. Sensus Healthcare, Inc. May 13, 2019 H.C. WAINWRIGHT & CO." (5/13/2019) 2. Maxim Group analysts commented, "Sensus reported lower-than-expected 1Q19 revenue and a wider-than- expected GAAP EPS loss due to a delayed shipment of seven SRT-100 Vision systems to its largest customer. We are slightly reducing our estimates to reflect the miss and a lower 2019 growth rate." (5/10/2019) 3. Northland Securities analysts commented, "We note that we were not allowed to ask questions on the call, hence we raise several questions in this note. Company commentary does not provide the adequate picture, for the reasons mentioned underneath. Maintain UP / $5 PT." (2/15/2019) Has Sensus Healthcare been receiving favorable news coverage? Media coverage about SRTS stock has been trending somewhat negative recently, InfoTrie reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sensus Healthcare earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the next several days. Who are some of Sensus Healthcare's key competitors? Some companies that are related to Sensus Healthcare include Accuray (ARAY), Inovio Pharmaceuticals (INO), Utah Medical Products (UTMD), Westaim (WEDXF), Vapotherm (VAPO), SeaSpine (SPNE), Neuronetics (STIM), Pulse Biosciences (PLSE), Iradimed (IRMD), Cytosorbents (CTSO), Apyx Medical (APYX), Alphatec (ATEC), Liquidia Technologies (LQDA), Endologix (ELGX) and T2 Biosystems (TTOO). What other stocks do shareholders of Sensus Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), iCAD (ICAD), Synergy Pharmaceuticals (SGYP), Zynerba Pharmaceuticals (ZYNE), Corbus Pharmaceuticals (CRBP), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), Viking Therapeutics (VKTX), AcelRx Pharmaceuticals (ACRX) and Cara Therapeutics (CARA). Who are Sensus Healthcare's key executives? Sensus Healthcare's management team includes the folowing people: Mr. Joseph C. Sardano, Chairman, CEO & Pres (Age 66)Mr. Arthur R. Levine, Chief Financial Officer (Age 61)Mr. Kalman Fishman, COO & CTO (Age 48)Dr. Ziv Karni, Chief Scientific Officer (Age 74)Mr. Michael Sardano, VP, Gen. Counsel, Corp. Sec. and Director of Governance & Regulatory (Age 30) When did Sensus Healthcare IPO? (SRTS) raised $20 million in an initial public offering on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company acted as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager. Who are Sensus Healthcare's major shareholders? Sensus Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Perkins Capital Management Inc. (2.33%), Garrison Bradford & Associates Inc. (0.66%), BlackRock Inc. (0.45%), B. Riley Financial Inc. (0.24%), BlueCrest Capital Management Ltd (0.19%) and Spark Investment Management LLC (0.13%). Company insiders that own Sensus Healthcare stock include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Institutional Ownership Trends for Sensus Healthcare. Which institutional investors are selling Sensus Healthcare stock? SRTS stock was sold by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. Company insiders that have sold Sensus Healthcare company stock in the last year include Arthur Levine, Joseph C Sardano, Kalman Fishman, Richard Golin and Stephen Brad Cohen. View Insider Buying and Selling for Sensus Healthcare. Which institutional investors are buying Sensus Healthcare stock? SRTS stock was purchased by a variety of institutional investors in the last quarter, including Garrison Bradford & Associates Inc., BlackRock Inc., B. Riley Financial Inc., BlueCrest Capital Management Ltd, Spark Investment Management LLC, B. Riley Wealth Management Inc., ExodusPoint Capital Management LP and BerganKDV Wealth Management LLC. View Insider Buying and Selling for Sensus Healthcare. How do I buy shares of Sensus Healthcare? Shares of SRTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Sensus Healthcare's stock price today? One share of SRTS stock can currently be purchased for approximately $5.30. How big of a company is Sensus Healthcare? Sensus Healthcare has a market capitalization of $87.55 million and generates $26.43 million in revenue each year. The company earns $-2,020,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. Sensus Healthcare employs 48 workers across the globe. What is Sensus Healthcare's official website? The official website for Sensus Healthcare is http://www.sensushealthcare.com. How can I contact Sensus Healthcare? Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The company can be reached via phone at 561-922-5808 or via email at [email protected] MarketBeat Community Rating for Sensus Healthcare (NASDAQ SRTS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 95 (Vote Outperform)Underperform Votes: 87 (Vote Underperform)Total Votes: 182MarketBeat's community ratings are surveys of what our community members think about Sensus Healthcare and other stocks. Vote "Outperform" if you believe SRTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRTS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Blockchain Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.